跳至主要内容
临床试验/NCT03902431
NCT03902431进行中(未招募)不适用

Implementation Research: Translating the ABCS Into HIV Care

University of Rochester2 个研究点 分布在 1 个国家目标入组 4,277 人开始时间: 2019年9月26日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
4,277
试验地点
2
主要终点
10-year CVD risk reduction

研究概览

简要总结

The overall objective of this project is to develop and rigorously test implementation strategies to address the gap in scientific knowledge of lower use of evidence-based interventions commonly referred to as the ABCS (aspirin, blood pressure control, cholesterol control, and smoking cessation)which contributes to the growing CVD morbidity and mortality among PLH.

详细描述

Our project has two major aims:

Aim 1: To assess the impact of the implementation of an evidence-based, multilevel strategy to reduce cardiovascular vascular disease (CVD) among PLH.

Aim 2: To assess the process of implementation of these strategies using RE-AIM QuEST. Using both quantitative and qualitative methods, we evaluate the process of implementation by assessing Reach, [Effectiveness addressed in Aim 1], Adoption, Implementation and Maintenance whilst integrating Qualitative Evaluation for Systematic Translation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
None

入排标准

年龄范围
40 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Serve a cohort of at least 100 HIV patients
  • Have an Electronic Health Record (EHR)
  • Agree to collaborate on implementing feasible adaptations of intervention strategies
  • Patient of the site with a diagnosis of HIV
  • Age 40-79 years
  • ≥5% risk for CVD as calculated using the ASCVD Risk Estimator Plus
  • Willing to participate
  • No plans to leave the site in the next 12 months
  • Proficient in either English or Spanish
  • Own a cell phone with texting capabilities
  • Clinicians:
  • Physicians, Physicians Assistants, or Nurse Practitioners who provide direct HIV care to patients
  • Work at a participating site
  • Willing to implement the project's intervention strategies

排除标准

  • Currently participating in another CVD trial
  • Have experienced a prior cardiac or vascular event such as myocardial infarction (MI) or cerebrovascular accident (CVA)
  • Have had a CVD procedure such as installation of a stent or angioplasty
  • Have peripheral vascular disease, intermittent claudication or peripheral arterial disease
  • Are pregnant
  • Lacks capacity to consent
  • Clinicians:
  • Planning to leave the site within the next 12 months

结局指标

主要结局

10-year CVD risk reduction

时间窗: 12 months

This will be based on the ACVSD risk calculator

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kevin Fiscella

Professor

University of Rochester

研究点 (2)

Loading locations...

相似试验